Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GLD vs GSK✓SelectedUSD · GSKGLD vs GSK performance historyLatest closeAs of-3.20%11/18
Stock and ETF performance explorer

GLD vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+196.3%
GSK return
+101.2%
Excess return
+95.1%
Maximum drawdown
-31.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.2%-1.3%-1.9%-3.1%
7D-6.6%-3.1%-3.4%-6.3%
30D-10.1%-0.9%-9.2%-10.1%
3M-14.4%-4.2%-10.2%-14.1%
6M-18.5%-1.6%-16.9%-18.5%
YTD-13.9%+2.6%-16.5%-14.3%
1Y-8.9%+6.2%-15.1%-9.5%
3Y+85.8%+55.0%+30.8%+76.7%
5Y+96.2%+42.8%+53.3%+86.6%
10Y+196.3%+102.1%+94.2%+165.6%
All+196.3%+101.2%+95.1%+165.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling